Study of immunogenicity and virulence of bovine herpesvirus 1 mutants deficient in the UL49 homolog, UL49.5 homolog and dUTPase genes in cattle

Vaccine

Volumn 15, Issue 10, 1997, Pages 1057-1064

  Liang, Xiaoping ^a,b   Chow, Betty ^a   Babiuk, Lorne A ^a,c  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

BHV 1; dUTPase; Recombinant vaccine; ULA9; ULA9.5

Indexed keywords

DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; NEUTRALIZING ANTIBODY; RECOMBINANT BOVINE HERPES VIRUS 1 VACCINE; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATTLE; CONTROLLED STUDY; ENZYME REGULATION; HERPES VIRUS; IMMUNOGENICITY; INTRANASAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; VACCINATION; VIRUS INFECTIVITY; VIRUS MUTATION; VIRUS TITRATION; VIRUS VIRULENCE;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, VIRAL; CATTLE; GENES, VIRAL; HERPESVIRUS 1, BOVINE; IMMUNIZATION; INJECTIONS, INTRAMUSCULAR; MUTATION; NEUTRALIZATION TESTS; PYROPHOSPHATASES; TIME FACTORS; VIRAL ENVELOPE PROTEINS; VIRAL STRUCTURAL PROTEINS; VIRAL VACCINES; VIRULENCE; VIRUS REPLICATION;

EID: 0030744392     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00008-X     Document Type: Article

References (27)

1. Gibbs, E.P.J. and Rweyemamu, M.M. Bovine herpesviruses. I. Bovine herpesvirus-1. Vet. Bull. 1977, 47, 317-343.
2. Yates, W.D.G. A review of infectious bovine rhinotracheitis virus, shipping fever pneumonia and viral-bacterial synergism in respiratory diseases in cattle. Can. J. Comp. Med. 1982, 46, 225-263.
3. van Drunen Littel van den Hurk, S., Tikoo, S.K., Liang, X. and Babiuk, L.A. Bovine herpesvirus-1 vaccines. Immunol. Cell Biol. 1993, 71, 405-420.
4. Kit, S., Kit, M. and McConnell, S. Intramuscular and intravaginal vaccination of pregnant cows with thymidine kinase-negative, temperature-resistant infectious bovine rhino-tracheitis virus (bovine herpes virus 1). Vaccine 1986, 4, 55-61.
5. Miller, J.M., Whetstone, C.A., Bello, L.J. and Lawrence, W.C. Determination of ability of a thymidine kinase-negative deletion mutant of bovine herpesvirus-1 to cause abortion in cattle. Am. J. Vet. Res. 1991, 52, 1038-1043.
6. Kit, S., Qavi, H., Gaines, J.D., Billingsley, P. and McConnell, S. Thymidine kinase-negative bovine herpesvirus type 1 mutant is stable and highly attenuated in calves. Arch. Virol. 1985, 86, 63-83.
7. Kit, S., Kit, M., DiMarchi, R., Little, S. and Gale, C. Modified-live infectious bovine rhinotracheitis virus (IBRV) vaccine expressing foot-and-mouth disease virus (FMDV) capsid protein epitopes on surface of hybrid virus particles. Adv. Exp. Med. Biol. 1991, 303, 211-220.
8. Kit, M., Kit, S., Little, S.P., Di-Marchi, R.D. and Gale, C. Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based vital vector which expresses foot-and-mouth disease epitopes. Vaccine 1991, 9, 564-572.
9. Kit, S., Kit, M., DiMarchi, R.D., Little, S.P. and Gale, C. Modified-live infectious bovine rhinotracheitis virus vaccine expressing monomer and dimer forms of foot-and-mouth disease capsid protein epitopes on surface of hybrid virus particles. Arch. Virol. 1991, 120, 1-17.
10. Whetstone, C.A., Miller, J.M., Seal, B.S., Bello, L.J. and Lawrence, W.C. Latency and reactivation of a thymidine kinase-negative bovine herpesvirus 1 deletion mutant. Arch. Virol. 1992, 122, 207-214.
11. van Engelenburg, F.A.C., Kaashoek, M.J. and Rijsewijik, F.A.M. et al. A glycoprotein E deletion of bovine herpesvirus 1 is avirulentin calves. J. Gen. Virol. 1994, 95, 2311-2318.
12. Liang, X., Babiuk, L.A. and Zamb, T.J. An in vivo study of a glycoprotein gill-negative bovine herpesvirus 1 (BHV-1) mutant expressing beta-galactosidase: evaluation of the role of gill in virus infectivity and its use as a vector for mucosal immunization. Virology 1992, 189, 629-639.
13. Liang, X., Tang, M., Manns, B., Babiuk, L.A. and Zamb, T.J. Identification and deletion mutagenesis of the bovine herpesvirus 1 dUTPase gene and a gene homologous to herpes simplex virus UL49.5. Virology 1993, 195, 42-50.
14. Liang, X., Chow, B. and Li, Y. et al. Characterization of bovine herpesvirus 1 UL49 homolog gene and product: bovine herpesvirus 1 UL49 homolog is dispensable for virus growth. J. Virol. 1995, 68, 3863-3867.
15. Liang, X., Chow, B., Raggo, C. and Babiuk, L.A. Bovine herpesvirus 1 UL49.5 homolog gene encodes a novel viral envelope protein that forms disulfide-linked complex with a second virion structural protein. J. Virol. 1995, 70, 1448-1454.
16. Kowalski, J., Gilbert, S.A., van Drunen Littel van den Hurk, S., van den Hurk, J., Babiuk, L.A. and Zamb, T.J. Heat-shock promoter-driven synthesis of secreted bovine herpesvirus glycoproteins in transfected cells. Vaccine 1993, 11, 1100-1107.
17. Elliott, G.D. and Meredith, D.M. The herpes simplex virus type 1 tegument protein VP22 is encoded by gene UL49. J. Gen. Virol. 1992, 73, 723-726.
18. Goding, C.R. and O'Hare, P. Herpes simplex virus Vmw65-Octamer binding protein interaction: a paradigm for combinatorial control of transcription. Virology 1989, 173, 363-367.
19. Hay, J. and Ruyechan, W.T. Regulation of herpes simplex virus type 1 gene expression. Curr. Top. Microbiol. Immunol. 1992, 179, 1-14.
20. Zhang, Y. and McKnight, J.L. Herpes simplex virus type 1 UL46 and UL47 deletion mutants lack VP11 and VP12 or VP13 and VP14, respectively, and exhibit altered viral thymidine kinase expression. J. Virol. 1993, 67, 1482-1492.
21. Meredith, D.M., Lindsay, J.A., Halliburton, I.W. and Whittaker, G.R. Post-translational modification of the tegument proteins (VP 13 and VP 14) of herpes simplex virus type 1 by glycosylation and phosphorylation. J. Gen. Virol. 1991, 72, 2771-2775.
22. Preston, C.M. and Notarianni, E.L. Poly(ADP-ribosyl)ation of a herpes simplex virus immediate early polypeptide. Virology 1983, 131, 492-501.
23. Blaho, J.A., Mitchell, C. and Roizman, B. An amino acid sequence shared by the herpes simplex virus 1 alpha regulatory proteins 0, 4, 22, and 27 predicts the nucleotidylylation of the UL21, UL31, UL47, and UL49 gene products. J. Biol. Chem. 1994, 269, 17401-17410.
24. Pinard, M.F., Simard, R. and Bibor-Hardy, V. DNA-binding proteins of herpes simplex virus type 1-infected BHK cell nuclear matrices. J. Gen. Virol. 1987, 68, 727-735.
25. Pyles, R.B., Sawtell, N.M. and Thompson, R.L. Herpes simplex virus type 1 dUTPase mutants are attenuated for neurovirulence, neuroinvasiveness, and reactivation from latency. J. Virol. 1992, 66, 6706-6713.
26. Eloit, J., Gilardi-Hebenstrelt, P., Toma, B. and Perricaudet, M. Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine. J. Gen. Virol. 1990, 71, 2425-2431.
27. Cox, W.K., Tartaglia, J. and Paoletti, E. Induction of cytotoxic lymphocytes by recombinant canarypox (ALVAC) and attenuated vaccinia (NYVAC) viruses expressing the HIV-1 envelope glycoprotein. Virology 1983, 195, 845-850.